Genome-wide association study of severity in multiple sclerosis

An Introduction to the Bootstrap

Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works

An Introduction to the Bootstrap

Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230 · see citing works

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969 · see citing works

From genomics to chemical genomics: new developments in KEGG

Kanehisa, M. I. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,126 · see citing works

KEGG for representation and analysis of molecular networks involving diseases and drugs

Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322 · see citing works

WebGestalt: an integrated system for exploring gene sets in various biological contexts

Zhang, B., Kirov, S. A., & Snoddy, J. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki475 · Cited by 1,801 · see citing works

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746 · see citing works

Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963 · see citing works

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800 · see citing works

NMDA receptors are expressed in oligodendrocytes and activated in ischaemia

Káradóttir, R. T., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005) · Nature · doi:10.1038/nature04302 · Cited by 773 · see citing works

The epidemiology of multiple sclerosis in Europe

Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Vécsei, L., & Milanov, I. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01342.x · Cited by 654 · see citing works

Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells

Stromnes, I. M., Cerretti, L., Liggitt, D., Harris, R. A., & Goverman, J. M. (2008) · Nature Medicine · doi:10.1038/nm1715 · Cited by 626 · see citing works

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury

Salter, M. G., & Fern, R. F. (2005) · Nature · doi:10.1038/nature04301 · Cited by 556 · see citing works

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., Yin, X., Trapp, B. D., McRory, J. E., Rehak, R., et al. (2005) · Nature · doi:10.1038/nature04474 · Cited by 504 · see citing works

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn388 · Cited by 476 · see citing works

NMDA receptor surface mobility depends on NR2A-2B subunits

Groc, L., Heine, M., Cousins, S. L., Stephenson, F. A., Lounis, B., Cognet, L., & Choquet, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605238103 · Cited by 376 · see citing works

Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations

Ioannidis, J. P. A., Patsopoulos, N. A., & Εvangelou, Ε. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000841 · Cited by 332 · see citing works

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Cree, B., Khan, O., BOURDETTE, D. N., Goodin, D., Cohen, J. A., Marrie, R. A., Glidden, D. V., Weinstock‐Guttman, B., Reich, D., Patterson, N. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 302 · see citing works

Impaired learning with enhanced hippocampal long‐term potentiation in PTPδ‐deficient mice

Uetani, N., Kato, K., Ogura, H., Mizuno, K., Kawano, K., Mikoshiba, K., Yakura, H., Asano, M., & Iwakura, Y. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2775 · Cited by 250 · see citing works

Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies

Laurie, D., Bartke, I., Schoepfer, R., Naujoks, K., & Seeburg, P. H. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00206-4 · Cited by 224 · see citing works

Multicenter Case-Control Study on Restless Legs Syndrome in Multiple Sclerosis: the REMS Study

The Italian REMS Study Group, Manconi, M., Ferini‐Strambi, L., Filippi, M., Bonanni, E., Iudice, A., Murri, L., Gigli, G. L., Fratticci, L., Merlino, G., et al. (2008) · SLEEP · doi:10.5665/sleep/31.7.944 · Cited by 211 · see citing works

Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis

Jen, Y., Manova, K., & Benezra, R. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199701)208:1 · Cited by 210 · see citing works

A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7.

Ewart, A. K., Morris, C. A., Ensing, G. J., Loker, J., Moore, C. A., Leppert, M., & Keating, M. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3226 · Cited by 182 · see citing works

Candidate-Gene Screening and Association Analysis at the Autism-Susceptibility Locus on Chromosome 16p: Evidence of Association at GRIN2A and ABAT

Barnby, G., Abbott, A., Sykes, N., Morris, A. P., Weeks, D. E., Mott, R., Lamb, J. A., Bailey, A. J., & Monaco, A. P. (2005) · The American Journal of Human Genetics · doi:10.1086/430454 · Cited by 180 · see citing works

Trans-synaptic Adhesions between Netrin-G Ligand-3 (NGL-3) and Receptor Tyrosine Phosphatases LAR, Protein-tyrosine Phosphatase δ (PTPδ), and PTPσ via Specific Domains Regulate Excitatory Synapse Formation

Kwon, S., Woo, J., Kim, S., Kim, H., & Kim, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061127 · Cited by 163 · see citing works

Genetic basis for clinical expression in multiple sclerosis

The Multiple Sclerosis Genetics Group, Barcellos, L. F., Oksenberg, J. R., Green, A. J., Bucher, P., Rimmler, J. B., Schmidt, S., Garcia, M., Lincoln, R., Pericak‐Vance, M. A., et al. (2002) · Brain · doi:10.1093/brain/awf009 · Cited by 154 · see citing works

Multiple sclerosis genetics—is the glass half full, or half empty?

Oksenberg, J., & Baranzini, S. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.91 · Cited by 152 · see citing works

Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration

Balaštík, M., Ferraguti, F., Pires‐daSilva, A., Lee, T. H., Álvarez-Bolado, G., Lu, K. P., & Gruß, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802261105 · Cited by 151 · see citing works

High prevalence of restless legs syndrome in multiple sclerosis

Manconi, M., Fabbrini, M., Bonanni, E., Filippi, M., Rocca, M. A., Murri, L., & Ferini‐Strambi, L. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01740.x · Cited by 136 · see citing works

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

DeLuca, G. C., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Lincoln, M. R., Montpetit, A., Pugliatti, M., Barnardo, M., RISCH, N. J., Sadovnick, A. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707731105 · Cited by 135 · see citing works

Mammalian Motoneuron Axon Targeting Requires Receptor Protein Tyrosine Phosphatases σ and δ

Uetani, N., Chagnon, M. J., Kennedy, T. E., Iwakura, Y., & Tremblay, M. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0386-06.2006 · Cited by 133 · see citing works

Multiple sclerosis susceptibility alleles in African Americans

Johnson, B. A., Wang, J., Taylor, E. M., Caillier, S. J., Herbert, J., Khan, O. A., Cross, A. H., Jager, P. L. D., Gourraud, P., Cree, B., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.81 · Cited by 126 · see citing works

Multiple sclerosis genetics: leaving no stone unturned

Oksenberg, J. R., & Barcellos, L. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364237 · Cited by 123 · see citing works

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Arning, L., Kraus, P. H., Valentin, S., Carsten Saft, C., Andrich, J., & Epplen, J. T. (2004) · Neurogenetics · doi:10.1007/s10048-004-0198-8 · Cited by 113 · see citing works

Alteration of the neurofilament sidearm and its relation to neurofilament compaction occurring with traumatic axonal injury

Okonkwo, D. O., Pettus, E. H., Moroi, J., & Povlishock, J. T. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01075-5 · Cited by 109 · see citing works

Identification of Genetic Loci Controlling the Characteristics and Severity of Brain and Spinal Cord Lesions in Experimental Allergic Encephalomyelitis

Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W., & Teuscher, C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64574-9 · Cited by 106 · see citing works

Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci

The International Multiple Sclerosis Genetics Consortium (IMSGC), McCauley, J. L., Zuvich, R. L., Beecham, A. H., De Jager, P. L., Konidari, I., Whitehead, P. L., Aubin, C., Ban, M., Pobywajlo, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp542 · Cited by 106 · see citing works

Receptor Tyrosine Phosphatase-δ Is a Homophilic, Neurite-Promoting Cell Adhesion Molecule for CNS Neurons

Wang, J., & Bixby, J. L. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0789 · Cited by 105 · see citing works

Genetics and pathogenesis of multiple sclerosis

Zuvich, R. L., McCauley, J. L., Pericak‐Vance, M. A., & Haines, J. L. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.08.003 · Cited by 98 · see citing works

Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD

Turic, D., Langley, K., Mills, S., Stephens, M., Lawson, D. C., Govan, C., Williams, N. M., van den Bree, M. V. D., Craddock, N., Kent, L., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001387 · Cited by 91 · see citing works

Familial effects on the clinical course of multiple sclerosis

Hensiek, A. E., Seaman, S. R., Barcellos, L. F., Oturai, A. B., Eraksoi, M., Cocco, E. E., Vécsei, L., Stewart, G. J., Dubois, B., Bellman-Strobl, J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000252822.53506.46 · Cited by 90 · see citing works

APOE epsilon variation in multiple sclerosis susceptibility and disease severity

Burwick, R. M., Ramsay, P. P., Haines, J. L., Hauser, S. L., Oksenberg, J. R., Pericak‐Vance, M. A., Schmidt, S., Compston, A., Sawcer, S. J., Cittadella, R., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000210531.19498.3f · Cited by 90 · see citing works

Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds

Andresen, J. M., Gayán, J., Cherny, S. S., Brocklebank, D., Alkorta‐Aranburu, G., Addis, E. A., Cardon, L. R., Housman, D. E., & Wexler, N. S. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045153 · Cited by 87 · see citing works

MGAT5 alters the severity of multiple sclerosis

Brynedal, B., Wojcik, J., Esposito, F., Debailleul, V., Yaouanq, J., Boneschi, F. M., Edan, G., Comı, G., Hillert, J. A., & Abderrahim, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.003 · Cited by 85 · see citing works

Familial factors influence disability in MS multiplex families

Brassat, D., Vuillemin-Azaïs, C., Yaouanq, J., Sémana, G., Reboul, J., Cournu‐Rebeix, I., Mertens, C., Edan, G., Lyon‐Caen, O., Clanet, M., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1632 · Cited by 84 · see citing works

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

(IMSGC), T. I. M. S. G. C. (2010) · Genes and Immunity · doi:10.1038/gene.2010.28 · Cited by 82 · see citing works

Glutamate Receptors in Neuroinflammatory Demyelinating Disease

Bolton, C., & Paul, C. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/93684 · Cited by 78 · see citing works

Molecular cloning of rat cDNAs for β and γ subtypes of 14-3-3 protein and developmental changes in expression of their mRNAs in the nervous system

Watanabe, M., Isobe, T., Ichimura, T., Kuwano, R., Takahashi, Y., & Kondo, H. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90082-z · Cited by 78 · see citing works

Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPδ and RPTPσ in the mouse

Schaapveld, R. Q. J., Schepens, J. T. G., Bächner, D., Attema, J., Wieringa, B., Jap, P. H. K., & Hendriks, W. J. A. J. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00119-1 · Cited by 67 · see citing works

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner

Arning, L., Carsten Saft, C., Wieczorek, S., Andrich, J., Kraus, P. H., & Epplen, J. T. (2007) · Human Genetics · doi:10.1007/s00439-007-0393-4 · Cited by 62 · see citing works

Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients

Jensen, C., Stankovich, J. M., van der Walt, A., Bahlo, M., Taylor, B. V., van der Mei, I. A. F., Foote, S. J., Kilpatrick, T. J., Johnson, L., Wilkins, E. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010003 · Cited by 53 · see citing works

The multiple sclerosis severity score (MSSS) predicts disease severity over time

Pachner, A. R., & Steiner, I. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.11.020 · Cited by 52 · see citing works

The E3‐ubiquitin ligase TRIM2 regulates neuronal polarization

Khazaei, M. R., Bunk, E. C., Hillje, A., Jahn, H. M., Riegler, E. M., Knoblich, J. A., Young, P., & Schwamborn, J. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06971.x · Cited by 51 · see citing works

Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-d-aspartate receptor subunit gene (GRIN2A) and schizophrenia

Tang, J., Chen, X., Xu, X., Wu, R., Zhao, J., Hu, Z., & Xia, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.022 · Cited by 48 · see citing works

Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3γ

Ye, S., Zhou, X., Lai, X., Li, Z., & Chen, X. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.70 · Cited by 41 · see citing works

Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly

Komoike, Y., Fujii, K., Nishimura, A., Hiraki, Y., Hayashidani, M., Shimojima, K. Y., Nishizawa, T., Higashi, K., Yasukawa, K., Saitsu, H., et al. (2010) · genesis · doi:10.1002/dvg.20607 · Cited by 40 · see citing works

The association of 14-3-3γ and actin plays a role in cell division and apoptosis in astrocytes

Chen, X., & Yu, A. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00895-1 · Cited by 39 · see citing works

Estrogen Receptor-1 (Esr1) and -2 (Esr2) Regulate the Severity of Clinical Experimental Allergic Encephalomyelitis in Male Mice

Polanczyk, M. J., Yellayi, S., Zamora, A., Subramanian, S., Tovey, M., Vandenbark, A. A., Offner, H., Zachary, J. F., Fillmore, P. D., Blankenhorn, E. P., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63752-2 · Cited by 38 · see citing works

Developmental regulation of subunit composition of extrasynaptic NMDA receptors in neocortical neurones

Mohrmann, R., Hatt, H. H., & Gottmann, K. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00012 · Cited by 32 · see citing works

14-3-3γ and Neuroglobin are New Intrinsic Protective Factors for Cerebral Ischemia

Dong, Y., Zhao, R., Chen, X., & Yu, A. C. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8142-4 · Cited by 31 · see citing works

Prognosis of the individual course of disease: the elements of time, hetereogeneity and precision

Däumer, M., Neuhaus, A., Herbert, J., & Ebers, G. C. (2009) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(09)71301-2 · Cited by 30 · see citing works

Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease

Peláez, I. M., Vogler, S., Strauß, U., Wernhoff, P., Pahnke, J., Brockmann, G. A., Moch, H., Thiesen, H., Rolfs, A., & Ibrahim, S. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi203 · Cited by 30 · see citing works

The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the Taiwanese population

Shyur, S., Wang, J., Lin, C. G.-J., Hsiao, Y.-H., Liou, Y.-H., Wu, Y.-J., & Wu, L. S.-H. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.79 · Cited by 16 · see citing works

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628 · see citing works

Multiple sclerosis

Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495 · see citing works

Multiple sclerosis genetics

Sawcer, S. J., Franklin, R. J. M., & Ban, M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70041-9 · Cited by 404 · see citing works

The immunology of multiple sclerosis

Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A., & Fugger, L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00718-z · Cited by 380 · see citing works

Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data

Zhang, M. J., Hou, K., Dey, K. K., Sakaue, S., Jagadeesh, K. A., Weinand, K., Taychameekiatchai, A., Rao, P., Pisco, A. O., Zou, J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01167-z · Cited by 302 · see citing works

The genetics of multiple sclerosis: an up‐to‐date review

Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01134.x · Cited by 278 · see citing works

Locus for severity implicates CNS resilience in progression of multiple sclerosis

International Multiple Sclerosis Genetics Consortium, Harroud, A., Stridh, P., McCauley, J. L., Saarela, J., van den Bosch, A. M. R., Engelenburg, H. J., Beecham, A. H., Alfredsson, L., Alikhani, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06250-x · Cited by 243 · see citing works

The neuropathobiology of multiple sclerosis

Woo, M. S., Engler, J. B., & Friese, M. A. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00823-z · Cited by 194 · see citing works

Disability in multiple sclerosis

Kister, I., Chamot, E., Salter, A. R., Cutter, G., Bacon, T. E., & Herbert, J. (2013) · Neurology · doi:10.1212/wnl.0b013e3182872855 · Cited by 176 · see citing works

Age Related Multiple Sclerosis Severity Score: Disability ranked by age

Manouchehrinia, A., Westerlind, H., Kingwell, E., Zhu, F., Carruthers, R., Ramanujam, R., Ban, M., Glaser, A., Sawcer, S., Tremlett, H., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690618 · Cited by 174 · see citing works

Genetics of Multiple Sclerosis: An Overview and New DirectionsPreprint

Patsopoulos, N. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028951 · Cited by 177 · see citing works

Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review

Ordoñez-Rodriguez, A., Román, P., Rueda‐Ruzafa, L., Campos-Ríos, A., & Cardona, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054624 · Cited by 138 · see citing works

Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course

Ventura, R. E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G. I., Herbert, J., & Blaser, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52894-z · Cited by 104 · see citing works

Genome‐wide association studies of multiple sclerosis

Cotsapas, C., & Mitrovic, M. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1018 · Cited by 89 · see citing works

DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis

Souren, N. Y., Gerdes, L. A., Lutsik, P., Gasparoni, G., Beltrán, E., Salhab, A., Kümpfel, T., Weichenhan, D., Plass, C., Hohlfeld, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09984-3 · Cited by 83 · see citing works

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

George, M. F., Briggs, F. B. S., Shao, X., Gianfrancesco, M. A., Kockum, I., Harbo, H. F., Celius, E. G., Bos, S. D., Hedström, A., Shen, L., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000087 · Cited by 86 · see citing works

Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome‐wide association studies

Liu, G., Jiang, Y., Wang, P., Feng, R., Jiang, N., Chen, X., Song, H., & Chen, Z. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07547.x · Cited by 83 · see citing works

Multiple sclerosis

Cotsapas, C. J., Mitrovič, M., & Hafler, D. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00046-6 · Cited by 83 · see citing works

Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis

Ponath, G. D., Lincoln, M. R., Levine-Ritterman, M., Park, C., Dahlawi, S., Mubarak, M., Sumida, T. S., Airas, L. M., Zhang, S., Isitan, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07785-8 · Cited by 80 · see citing works

Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course

Bove, R. M., Secor, E. A., Healy, B. C., Musallam, A., Vaughan, T. E., Glanz, B. I., Greeke, E. E., Weiner, H. L., Chitnis, T., Wicks, P. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059707 · Cited by 68 · see citing works

Multiple sclerosis genetics

Cree, B. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00009-1 · Cited by 58 · see citing works

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms

Haddad, F., Dokmak, G., & Karaman, R. (2022) · Life · doi:10.3390/life12050682 · Cited by 58 · see citing works

Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Coorssen, J. R., & Mahns, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572186 · Cited by 55 · see citing works

Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation

Woo, M. S., Ufer, F., Rothammer, N., Liberto, G. D., Binkle-Ladisch, L., Haferkamp, U., Sonner, J. K., Engler, J. B., Hornig, S., Bauer, S., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201290 · Cited by 53 · see citing works

Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis

Caminero, A. B., Comabella, M., & Montalbán, X. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04484.x · Cited by 54 · see citing works

Genetics of multiple sclerosis

Baranzini, S. E., & Nickles, D. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283533a93 · Cited by 52 · see citing works

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

Jokubaitis, V., Campagna, M. P., Ibrahim, O., Stankovich, J. M., Kleinová, P., Matesanz, F., Hui, D., Eichau, S., Slee, M., Lechner‐Scott, J., et al. (2022) · Brain · doi:10.1093/brain/awac449 · Cited by 60 · see citing works

Recent Advances and Future Challenges in the Genetics of Multiple Sclerosis

Lill, C. M. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00130 · Cited by 51 · see citing works

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis

Hecker, M., Bühring, J., Fitzner, B., Rommer, P. S., & Zettl, U. K. (2021) · Biomolecules · doi:10.3390/biom11101510 · Cited by 48 · see citing works

Epigenetic insights into multiple sclerosis disease progression

Kular, L., & Jagodic, M. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13045 · Cited by 46 · see citing works

Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese — A case control study

Wang, H., Zhong, X., Wang, K., Qiu, W., Li, J., Dai, Y., & Hu, X. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.005 · Cited by 45 · see citing works

Significant expansion of the REST/NRSF cistrome in human versus mouse embryonic stem cells: potential implications for neural development

Rockowitz, S., & Zheng, D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv514 · Cited by 42 · see citing works

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

Hughes, S., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand’Maison, F., Duquette, P., Girard, M., Grammond, P., Oreja-Guevara, C., et al. (2012) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · doi:10.1136/jnnp-2011-301051 · Cited by 43 · see citing works

Ten years of proteomics in multiple sclerosis

Farias, A. S., Pradella, F., Schmitt, A., Santos, L. M. B., & Martins‐de‐Souza, D. (2014) · PROTEOMICS · doi:10.1002/pmic.201300268 · Cited by 40 · see citing works

Integrating Mendelian randomization and multiple-trait colocalization to uncover cell-specific inflammatory drivers of autoimmune and atopic disease

McGowan, L. M., Smith, G. D., Gaunt, T. R., & Richardson, T. G. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz155 · Cited by 40 · see citing works

Epistasis and immunity: the role of genetic interactions in autoimmune diseases

Rose, A. M., & Bell, L. C. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03623.x · Cited by 38 · see citing works

Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus

Ottoboni, L., Frohlich, I. Y., Lee, M. H., Healy, B. C., Keenan, B. T., Xia, Z., Chitnis, T., Guttmann, C. R. G., Khoury, S. J., Weiner, H. L., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000436612.66328.8a · Cited by 36 · see citing works

Post‐mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms

Fransen, N. L., Crusius, J. B. A., Smolders, J., Mizee, M. R., van Eden, C. G., Luchetti, S., Remmerswaal, E. B. M., Hamann, J., Mason, M. R. J., & Huitinga, I. (2020) · Brain Pathology · doi:10.1111/bpa.12760 · Cited by 37 · see citing works

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

Watanabe, M., Nakamura, Y., Sato, S., Niino, M., Fukaura, H., Tanaka, M., Ochi, H., Kanda, T., Takeshita, Y., Yokota, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79833-7 · Cited by 39 · see citing works

Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians

Sokolova, E. А., Malkova, N. A., Korobko, D. S., Rozhdestvenskiĭ, A. S., Kakulya, A. V., Ханох, Е. В., Ra, D., Платонов, Ф. А., Popova, T., Геннадьевна, А. Е., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061032 · Cited by 36 · see citing works

Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment

Zhou, L., & Matsushima, G. K. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.002 · Cited by 35 · see citing works

Self-reported levels of education and disability progression in multiple sclerosis

D'hooghe, M. B., Haentjens, P., Van Remoortel, A., De Keyser, J., & Nagels, G. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12555 · Cited by 35 · see citing works

Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease

Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 35 · see citing works

Genetics and functional genomics of multiple sclerosis

Kim, W., & Patsopoulos, N. A. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-021-00907-3 · Cited by 34 · see citing works

Genome-wide association studies in neurology.

Tan, M., Jiang, T., Tan, L., & Yu, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.11.12 · Cited by 33 · see citing works

Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants

Li, C. F., Zhou, R. W., Mkhikian, H., Newton, B. L., Yu, Z., & Demetriou, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.008 · Cited by 33 · see citing works

Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment

Mahurkar, S., Moldovan, M., Suppiah, V., & O'Doherty, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057655 · Cited by 22 · see citing works

Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions

de Boer, A., van den Bosch, A. M. R., Mekkes, N., Fransen, N. L., Dagkesamanskaia, E., Hoekstra, E., Hamann, J., Smolders, J., Huitinga, I., & Holtman, I. R. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02742-w · Cited by 29 · see citing works

Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study

Crielaard, L., Kavaliūnas, A., Ramanujam, R., Olsson, T. P., Hillert, J. A., Stridh, P., Kockum, I. S., & Manouchehrinia, A. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319913 · Cited by 30 · see citing works

Genetic predictors of relapse rate in pediatric MS

Graves, J. S., Barcellos, L. F., Shao, X., Noble, J. A., Mowry, E. M., Quach, H., Belman, A. L., Casper, T. C., Krupp, L., & Waubant, E. L. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515624269 · Cited by 28 · see citing works

Genetic variation in the geneLRP2increases relapse risk in multiple sclerosis

Zhou, Y., Graves, J. S., Simpson, S., Charlesworth, J., van der Mei, I. A. F., Waubant, E. L., Barcellos, L. F., Belman, A. L., Krupp, L., Lucas, R. M., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315971 · Cited by 28 · see citing works

Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes

Calvier, L., Demuth, G., Manouchehri, N., Wong, C. H. Y., Sacharidou, A., Mineo, C., Shaul, P. W., Monson, N. L., Kounnas, M. Z., Stüve, O., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7675 · Cited by 30 · see citing works

TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis

Paltser, G., Liu, X. J., Yantha, J., Winer, S., Tsui, H., Wu, P., Maezawa, Y., Cahill, L. S., Laliberté, C. L., Ramagopalan, S. V., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00329 · Cited by 26 · see citing works

Next generation sequencing for neurological diseases: New hope or new hype?

Keogh, M. J., & Chinnery, P. F. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.09.030 · Cited by 25 · see citing works

Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis

Giacalone, G., Clarelli, F., Osiceanu, A. M., Guaschino, C., Brambilla, P., Sorosina, M., Liberatore, G., Zauli, A., Esposito, F., Rodegher, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564590 · Cited by 25 · see citing works

Acquired channelopathies as contributors to development and progression of multiple sclerosis

Schattling, B., Eggert, B., & Friese, M. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.006 · Cited by 24 · see citing works

A genetic basis for multiple sclerosis severity: Red herring or real?

Jokubaitis, V., & Butzkueven, H. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.08.007 · Cited by 22 · see citing works

Involvement of Genetic Factors in Multiple Sclerosis

Ferrè, L., Filippi, M., & Esposito, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.612953 · Cited by 22 · see citing works

Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real‐World Cohort

Kreft, K. L., Uzochukwu, E., Loveless, S., Willis, M., Wynford‐Thomas, R., Harding, K. E., Holmans, P., Lawton, M., Tallantyre, E. C., & Robertson, N. P. (2023) · Annals of Neurology · doi:10.1002/ana.26831 · Cited by 22 · see citing works

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

Kalinčík, T., Guttmann, C. R. G., Krásenský, J., Vaněčková, M., Lelková, P., Týblová, M., Seidl, Z., Jager, P. L. D., Havrdová, E., & Horáková, D. (2013) · Genes and Immunity · doi:10.1038/gene.2013.17 · Cited by 21 · see citing works

Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records

RESTREPO, N. A., Butkiewicz, M., McGrath, J. A., & Crawford, D. C. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00185 · Cited by 21 · see citing works

Gene variants of adhesion molecules act as modifiers of disease severity in MS

Dardiotis, E., Panayiotou, E., Provatas, A., Christodoulou, K., Hadjisavvas, A., Antoniades, A., Lourbopoulos, A., Pantzaris, M., Grigoriadis, N., Hadjigeorgiou, G., et al. (2017) · Neurology: Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000350 · Cited by 20 · see citing works

Feasibility study for remote assessment of cognitive function in multiple sclerosis

Barcellos, L. F. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/8.1084 · Cited by 21 · see citing works

The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults

Graves, J. S., Barcellos, L. F., Simpson, S., Belman, A. L., Lin, R., Taylor, B. V., Ponsonby, A., Dwyer, T., Krupp, L., Waubant, E. L., et al. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.10.008 · Cited by 21 · see citing works

A higher burden of multiple sclerosis genetic risk confers an earlier onset

Misicka, E., Davis, M. F., Kim, W., Brugger, S. W., Beales, J. T., Loomis, S. J., Bronson, P. G., & Briggs, F. B. S. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211053155 · Cited by 20 · see citing works

Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors

Misicka, E., Sept, C. E., & Briggs, F. B. S. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09850-z · Cited by 20 · see citing works

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon

Wang, E., Zhao, Y., Monaco, A., Uccellini, L., Kirkwood, J. M., Spyropoulou‐Vlachou, M., Panelli, M. C., Marincola, F. M., & Gogas, H. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040805 · Cited by 18 · see citing works

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Reilly, G. D., Mahkawnghta, A. S., Jelinek, P. L., Livera, A. M. D., Weiland, T. J., Brown, C. R., Taylor, K. L., Neate, S. L., Jelinek, G. A., & Marck, C. H. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00229 · Cited by 18 · see citing works

Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms

Shepard, C. J., Cline, S. G., Hinds, D., Jahanbakhsh, S., & Prokop, J. W. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00120.2018 · Cited by 17 · see citing works

Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing

van Rensburg, S. J., Peeters, A. V., van Toorn, R., Schoeman, J. F., Moremi, K. E., Heerden, C. J. V., & Kotze, M. J. (2019) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2019.100465 · Cited by 15 · see citing works

Genome-Wide Multiple Sclerosis Association Data and Coagulation

Starza, S. L., Ferraldeschi, M., Buscarinu, M. C., Romano, S., Fornasiero, A., Mechelli, R., Umeton, R., Ristori, G., & Salvetti, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00095 · Cited by 14 · see citing works

Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach

Ferrè, L., Clarelli, F., Pignolet, B., Mascia, E., Frasca, M., Santoro, S., Sorosina, M., Bucciarelli, F., Moiola, L., Martinelli, V., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13010122 · Cited by 14 · see citing works

Association study of rs7799039, rs1137101 and rs8192678 gene variants with disease susceptibility/severity and corresponding LEP, LEPR and PGC1A gene expression in multiple sclerosis

Kolić, I., Stojković, L., Stanković, A., Stefanović, M., Dinčić, E., & Živković, M. (2021) · Gene · doi:10.1016/j.gene.2021.145422 · Cited by 13 · see citing works

Contribution of common risk variants to multiple sclerosis in Orkney and Shetland

Barnes, C. L. K., Hayward, C., Porteous, D. J., Campbell, H. J., Joshi, P. K., & Wilson, J. F. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00914-w · Cited by 12 · see citing works

The role of the Epstein–Barr Virus receptor CD21 in Multiple Sclerosis

Toepfner, N., Cepok, S., Grummel, V., & Hemmer, B. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.11.002 · Cited by 12 · see citing works

TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population

Javor, J., Shawkatová, I., Ďurmanová, V., Párnická, Z., Čierný, D., Michalík, J., Čopíková‐Cudráková, D., Smahová, B., Gmitterová, K., Peterajová, Ľ., et al. (2018) · International Journal of Immunogenetics · doi:10.1111/iji.12388 · Cited by 14 · see citing works

Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 11 · see citing works

Functional relevance for multiple sclerosis-associated genetic variants

Lin, X., Deng, F., Mo, X., Wu, L., & Lei, S. (2014) · Immunogenetics · doi:10.1007/s00251-014-0803-4 · Cited by 10 · see citing works

Not all roads lead to the immune system: The Genetic Basis of Multiple Sclerosis Severity Implicates Central Nervous System and Mitochondrial InvolvementPreprint

Jokubaitis, V., Ibrahim, O., Stankovich, J. M., Kleinová, P., Matesanz, F., Hui, D., Eichau, S., Slee, M., Lechner‐Scott, J., Lea, R. A., et al. (2022) · medRxiv · doi:10.1101/2022.02.04.22270362 · Cited by 10 · see citing works

Unlocking Multiple Sclerosis Genetics

Sahi, N., Ciccarelli, O., Houlden, H., & Chard, D. (2025) · Neurology · doi:10.1212/wnl.0000000000214141 · Cited by 9 · see citing works

Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients

Smets, I., Goris, A., Vandebergh, M., Demeestere, J., Sunaert, S. G., Dupont, P. J., & Dubois, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-81035-8 · Cited by 8 · see citing works

Role of Socioeconomic Position in Multiple Sclerosis Etiology

Briggs, F. B. S., Green, M. C., & Weintraub, M. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.22 · Cited by 8 · see citing works

Multiple Sclerosis: Individualized Disease Susceptibility and Therapy Response

Pravica, V., Marković, M., Cupic, M. D., Savić, E., Popadic, D. M., Drulovic, J. S., & Mostarica‐Stojković, M. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.12.113 · Cited by 7 · see citing works

Interferon beta treatment of multiple sclerosis increases serum interleukin-7

Lundström, W., Hermanrud, C. E., Sjöstrand, M., Brauner, S., Wahren‐Herlenius, M., Olsson, T. P., Karrenbauer, V. D., Hillert, J. A., & Fogdell‐Hahn, A. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514532700 · Cited by 7 · see citing works

Genome-Wide Association of New-Onset Hypertension According to Renin Concentration: The Korean Genome and Epidemiology Cohort Study

Lee, S., Park, B., Hong, K., & Jung, D. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9040104 · Cited by 8 · see citing works

Contribution of Genome-Wide Association Studies to Scientific Research: A Pragmatic Approach to Evaluate Their Impact

Ricigliano, V. A. G., Umeton, R., Germinario, L., Alma, E., Briani, M., Segni, N. D., Montesanti, D., Pierelli, G., Cancrini, F., Lomonaco, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071198 · Cited by 7 · see citing works

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials

Loomis, S. J., Sadhu, N., Fisher, E., Gafson, A., Huang, Y., Yang, C., Hughes, E. E., Marshall, E., Herman, A. H., John, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41099-0 · Cited by 7 · see citing works

Association analysis of cytokine receptors’ genes polymorphisms with clinical features of multiple sclerosis

Кулакова, О. Г., Bashinskaya, V. V., Tsareva, E., Boyko, A. N., Favorova, O. O., & Gusev, E. I. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611610210-15 · Cited by 7 · see citing works

Transcriptomic analysis of Multiple Sclerosis patient-derived monocytes by RNA-Sequencing for candidate gene discovery

Almsned, F. M., Lipsky, R. H., & Jafri, M. S. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100563 · Cited by 6 · see citing works

The “6B” Strategy: Build Back a Better Blood–Brain Barrier

Calvier, L., Alexander, A., & Herz, J. (2022) · Immuno · doi:10.3390/immuno2030032 · Cited by 6 · see citing works

Genetic Predisposition, Humans

Jordan, M. A., Field, J., Butzkueven, H., & Baxter, A. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00026-5 · Cited by 6 · see citing works

Genotype–phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis

Harding, K. E., Ingram, G., Cossburn, M., Hirst, C. L., Pickersgill, T. P., Ben‐Shlomo, Y., & Robertson, N. P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.040 · Cited by 5 · see citing works

Is There a Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?

Albrekkan, F. M., Bachir, S., Jumaa, M. A., Zaidi, S. F., & Medhkour, A. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.04.027 · Cited by 5 · see citing works

Genetic Predisposition, Humans

Jordan, M. A., & Baxter, A. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00023-3 · Cited by 4 · see citing works

Multiple Sclerosis

Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00007-0 · Cited by 4 · see citing works

Epidemiology and Genetics

Roostaei, T., & Jager, P. L. D. (2019) · Current clinical neurology · doi:10.1007/978-3-030-24436-1_4 · Cited by 4 · see citing works

The Genetics of Multiple Sclerosis

Miner, A. E., Dastgheyb, N., Palomino, M. M., & Graves, J. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_11 · Cited by 3 · see citing works

Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing–Remitting Multiple Sclerosis Patients

Ferrari, M., Vecchio, D., D’Alfonso, S., Gemma, A., Marino, F., Comi, C., & Cosentino, M. (2024) · Genes · doi:10.3390/genes15060736 · Cited by 3 · see citing works

Role of Genetic Factors in Pathophysiology of Multiple Sclerosis

Goris, A., Dubois, B., & Hilven, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00008-7 · Cited by 3 · see citing works

Contribution of genomic variation to the severity of multiple sclerosis

Кулакова, О. Г., Matveeva, N. A., Сергеевич, К. И., Boyko, A. N., & Favorova, O. O. (2025) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2025-1-78-84 · Cited by 2 · see citing works

The Genetic Basis of Multiple Sclerosis Severity Suggests Central Nervous System Involvement (S5.005)

Harroud, A. (2022) · Neurology · doi:10.1212/wnl.98.18_supplement.3650 · Cited by 2 · see citing works

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

Jokubaitis, V., Campagna, M. P., Ibrahim, O., Stankovich, J. M., Kleinová, P., Matesanz, F., Hui, D., Eichau, S., Slee, M., Lechner‐Scott, J., et al. (2022) · Brain · doi:10.1093/brain/awac449 · Cited by 60 · see citing works

Not all roads lead to the immune system: The Genetic Basis of Multiple Sclerosis Severity Implicates Central Nervous System and Mitochondrial InvolvementPreprint

Jokubaitis, V., Ibrahim, O., Stankovich, J. M., Kleinová, P., Matesanz, F., Hui, D., Eichau, S., Slee, M., Lechner‐Scott, J., Lea, R. A., et al. (2022) · medRxiv · doi:10.1101/2022.02.04.22270362 · Cited by 10 · see citing works

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

George, M. F., Briggs, F. B. S., Shao, X., Gianfrancesco, M. A., Kockum, I., Harbo, H. F., Celius, E. G., Bos, S. D., Hedström, A., Shen, L., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000087 · Cited by 86 · see citing works

GP.1 The genetic basis of multiple sclerosis severity

Harroud, A. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.85